Search Results 951-960 of 17835 for monoclonal antibody

1. Mayo Clinic launches Cardiac Sarcoidosis Clinic

   Physicians at Mayo Clinic have used rituximab, a monoclonal antibody directed against the CD20 antigen on the surface of B lymphocytes, to treat patients with ...

2. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin ...

3. Biomarkers To Predict For And Monitor Response To PD-1/PD-L1 Inhibitors - Mayo Clinic

   ... monoclonal antibody is deemed appropriate). • Recommendation by the treating provider to initiate therapy with a commercially available, FDA approved, anti ...

4. Treatment Of Antibody-Mediated Rejection (ABMR) With CarBel - Mayo Clinic

   About this study. The purpose of this study is to see: 1. If using these two drugs (carfilzomib and belatacept) together is safe

5. Brain Tumor Surgery Clinical Trials - Mayo Clinic Research

   Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

6. Faculty and staff - Antibody Hybridoma Core - Mayo Clinic Research

   View faculty and staff of Mayo Clinic's Antibody Hybridoma Core.

7. A Study to Evaluate the Effectiveness and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients - Mayo Clinic

   The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

8. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins); Grade > 1 peripheral ...

9. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

   For monoclonal antibody therapy, the subject is < 1 half-life or <4 weeks from the last dose. 7. Chronic, systemically administered glucocorticoids in doses ...

10. Mayo researchers correlate specific antibody with relapse of neurological disorder

    ... antibody, myelin oligodendrocyte glycoprotein — also known as MOG, and an increased risk of recurring attacks in these individuals. Mayo Clinic neurologists ...